Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
49.82
+1.06 (2.17%)
At close: Jul 2, 2026, 4:00 PM EDT
49.97
+0.15 (0.30%)
After-hours: Jul 2, 2026, 5:36 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $3.48 billion as of July 2, 2026. Its market cap has increased by 225.19% in one year.
Market Cap
3.48B
Enterprise Value
3.03B
1-Year Change
225.19%
Ranking
Category
Stock Price
$49.82
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $3.48B, an increase of 257.14%. That is a compound annual growth rate of 46.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 3.48B | 280.61% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 3.85B |
| Arcus Biosciences | 3.81B |
| Dyne Therapeutics | 3.81B |
| Structure Therapeutics | 3.80B |
| Parabilis Medicines | 3.77B |
| IDEAYA Biosciences | 3.58B |
| Beam Therapeutics | 3.46B |
| Alumis | 3.38B |